Sustainability and Holistic Assessment of Technologies and Biotechnologies

March 24/25, 2011 - Caen/France - University of Caen, Human Sciences (MRSH), Esplanade de la Paix

Co-organisers:

University of Caen MRSH-CNRS; Risk Pole; CRIIGEN; ENSSER; Foundation for Citizen Sciences; GenØk; Society of Environmental Health in Western France

Program & Lectures

lectures are currently uploaded

Mar 24 (08:30) - Opening Session

Josette Travert, President, University of Caen

Jean-Karl Deschamps, Vice-President, Regional Council of Basse-Normandie

Pascal Buléon, Director, Maison de la Recherche en Sciences Humaines (MRSH), University of Caen

Corinne Lepage, Member of the European Parliament, Alliance of Liberals and Democrats for Europe (ALDE)

Angelika Hilbeck, Chairperson of ENSSER & Member of the Scientific Council of the Comité de Recherche et d'Information Indépendantes sur le génie Génétique (CRIIGEN)

Mar 24 (09:00) - European Situation and Trends

    State of the art in European assessment of technologies and biotechnologies, in European laws and legal contexts
    Corinne Lepage (MEP-ALDE), France
    Environmental and health risk assessment in the EU - possible improvements
    David Gee, Coordinator for Emerging Issues, European Environmental Agency (EEA), Denmark

Mar 24 (10:20) - American Situation and Trends

    State of the art and future possible directions in American environmental and health assessments of technologies and biotechnologies
    Prof Louise Vandelac, Centre de recherche interdisciplinaire sur la biologie, la santé et l'environnement (CINBOISE), University of Quebec in Montreal, Canada

Mar 24 (10:40) - Health Issues

    What is really environmental health? The case of rivers polluted by medicinal drugs, chemicals and pesticides or GMO residues
    Dr Joël Spiroux de Vendômois, Society for Environmental Health - Normandie, France
    Environmental health risk assessment in the EU: state of the art and future directions
    Dr Andreas Gies, Federal Environment Agency (Umweltbundesamt, UBA), Germany
    The nutritional assessment of GMOs before commercialization, how to approach a comprehensive assessment
    Prof Federico Infascelli & Dr Raffaella Tudisco, University of Napoli, Italy
    The genetic engineering assessment itself is not holistic - implications on public transparency, regional agriculture in Italy, and on labeling as well as future possibilities
    Prof Marcello Buiatti, University of Firenze & Italian Commission on Genetic Engineering, Italy
    What possible health and environmental assessment for nanotechnologies?
    Prof Julian Filser & Dr Jan Köser, University of Bremen, Germany
    How the neglected effects of chemicals, pesticides, drugs, biotechnologies and nanotechnologies can be taken into account in the future
    Prof Gilles-Eric Séralini, University of Caen & CRIIGEN, France

Mar 24 (14:00) - Environmental and Geographical Issues

    The lack of assessment of the impact new technologies on the microbial world and the soil – possible improvements
    Dr Christian Vélot, University Paris-South (Orsay), France
    Bringing the geographical approach to assessment and management of technological risks: application to Normandy
    Prof Olivier Maquaire, University of Caen, France
    Environmental assessment of biotechnologies in the future
    Dr. Angelika Hilbeck, Swiss Federal Institute of Technology Zurich (ETH Zürich), Switzerland

Mar 24 (15:30) - Economical, Legal and Ethical Issues

    Pesticide and agricultural GMO registration in the EU: internal controversies
    Dr. András Székács, Department of Ecotoxicology and Environmental Chemistry, Plant Protection Institute, Hungarian Academy of Sciences, Hungary
    Economical assessment of technologies and biotechnologies : past, present and future: how to encompass it in biological assessment?
    Dr. Iulie Aslaksen, Statistics Norway & GenØk, Norway
    Lacks and possible improvements in European Union law concerning GMOs
    Prof Jean-Michel Panoff & Dr Marie-Pierre Maurin, University of Caen & CRIIGEN, France
    Patents and sustainable development in the Southern and Northern hemispheres
    Dr. Hartmut Meyer, Scientific Coordinator, ENSSER
    Science policy and anomie - Risk appraisal interface
    Dr. David Quist, GenØk, Norway

Mar 25 (08:30) - Social Issues

    How to better involve the society in technological and biotechnological assessments?
    Claudia Neubauer, Fondation Citoyennes Science (FSC), France
    Public participation in EU assessment of biotechnologies and future directions – a European study
    Dr Frédérick Lemarchand, Risk Cluster Sociology, University of Caen, France
    Nanotechnologies risk assessment
    Prof Christian Papilloud, Sociology, University of Caen, France
    Social acceptability of new technologies. What about the future?
    Dr Michelle Dobré,  Centre National de la Recherche Scientifique (CNRS), Centre d'Etude et de Recherche sur les Risques et les Vulnérabilités (C.E.R.R.e.V.), University of Caen, France
    Public information and participation in technology and biotechnology assessment
    Prof Mercy W. Kamara, University of Roskilde, Denmar

Conference

Poster Session

Regulation of genetically modified plants: state-of-art and improvements
(Mesagne et al.)

A cognitive assessment of decision-making criteria applied in long-term investment: a conflict between ethics and maximizing profit?
(Laville & Leneveu)

Evaluation of the combined effects of PCBs and Roundup® on human embryonic cells viability
(Defarge & Séralini)

Use of herbicide (Roundup®): potential influence on soil metals lability and on radish metal uptake
(Baraud & Leleyter)

Effects of Roundup and glyphosate on three food microbes: Geotrichum candidum, Lactococcus lactis subsp. cremoris and Lactobacillus delbrueckii subsp. bulgaricus
(Clair et al.)

Public debate at the Regional Council of the Lower Normandy

Sustainable assessment of technologies in Basse-Normandie: programme

Evaluation durable des technologies en Basse-Normandie: programme